MARCUS CORP·4

Feb 13, 5:53 PM ET

Gramz Mark A 4

4 · MARCUS CORP · Filed Feb 13, 2026

Research Summary

AI-generated summary of this filing

Updated

Marcus Corp (MCS) President Mark A. Gramz Receives Restricted Stock

What Happened
Mark A. Gramz, President of Marcus Theatres (Marcus Corp / MCS), was granted 16,400 restricted shares on February 11, 2026. The reported acquisition price is $0, indicating these were a compensation award (restricted stock), not an open-market purchase. There was no immediate cash received from the transaction.

Key Details

  • Transaction date: February 11, 2026 (Form 4 filed February 13, 2026 — appears timely within required reporting window).
  • Transaction type/code: Award / Acquisition (A).
  • Shares granted: 16,400 restricted shares; reported price $0 (compensation grant).
  • Shares owned after transaction: Not reported in the filing.
  • Footnote F1: These restricted shares vest 50% after the 2nd anniversary of the grant and 100% after the 3rd anniversary.
  • Footnotes F2 & F3: Filing also references prior option grants with multi-year vesting schedules (40–100% over 2–5 years and 50–100% over 2–4 years) — these relate to earlier option awards, not this restricted stock grant.

Context
Restricted stock grants are compensation and typically subject to vesting and forfeiture until vested; because the grant price is $0, there was no cash purchase and no immediate sale of shares. Such awards are common for executive compensation and do not by themselves indicate a buy or sell signal.

Insider Transaction Report

Form 4
Period: 2026-02-11
Gramz Mark A
Pres., Marcus Theatres
Transactions
  • Award

    Common Stock

    [F1]
    2026-02-11+16,40052,161 total
Holdings
  • Stock Option (Right to Buy)

    [F2]
    Exercise: $31.20Exp: 2027-02-28Common Stock (3,500 underlying)
    3,500
  • Stock Option (Right to Buy)

    [F3]
    Exercise: $27.00Exp: 2028-02-27Common Stock (3,500 underlying)
    3,500
  • Stock Option (Right to Buy)

    [F3]
    Exercise: $41.90Exp: 2029-02-26Common Stock (3,500 underlying)
    3,500
  • Stock Option (Right to Buy)

    [F3]
    Exercise: $28.88Exp: 2030-02-25Common Stock (3,500 underlying)
    3,500
  • Stock Option (Right to Buy)

    [F3]
    Exercise: $12.71Exp: 2030-05-08Common Stock (1,750 underlying)
    1,750
  • Stock Option (Right to Buy)

    [F3]
    Exercise: $21.84Exp: 2031-03-09Common Stock (4,200 underlying)
    4,200
  • Stock Option (Right to Buy)

    [F3]
    Exercise: $17.04Exp: 2032-03-08Common Stock (3,500 underlying)
    3,500
  • Stock Option (Right to Buy)

    [F3]
    Exercise: $15.99Exp: 2033-03-07Common Stock (27,500 underlying)
    27,500
Footnotes (3)
  • [F1]Restricted stock granted February 11, 2026 vests and becomes exercisable as follows: 50% after 2nd anniversary of date of grant and 100% after 3rd anniversary of date of grant.
  • [F2]The options originally granted vest as follows: 40% after 2nd anniversary of the date of grant; 60% after 3rd anniversary; 80% after 4th anniversary; and 100% after 5 years.
  • [F3]The options originally granted vest as follows: 50% after 2nd anniversary of the date of grant; 75% after 3rd anniversary; and 100% after 4 years.
Signature
/s/ Steven R. Barth, Attorney-in-Fact for Mark A. Gramz|2026-02-13

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4